AFTD is excited to share that The Lauder Foundation and the Samuel I. Newhouse Foundation have each committed $5 million to create Het Treat FTD-fonds, which will accelerate clinical trials for FTD over the next decade. The fund, a joint program of AFTD and the Alzheimer’s Drug Discovery Foundation (ADDF), has the potential to advance treatments for other neurodegenerative diseases, such as Alzheimer’s, ALS and Parkinson’s. Read the persbericht, and see coverage of the announcement in USA Today, Alzheimer’s News Today, NJ.Com, The Chronicle of Philanthropy, En Practical Neurology.